Multicenter phase II study of capecitabine plus oxaliplatin in older patients with advanced gastric cancer: the Tokyo Cooperative Oncology Group (TCOG) GI-1601 study
ConclusionsThese findings demonstrate CapeOX's efficacy and safety in older AGC patients.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research
More News: Anemia | Anorexia | Cancer | Cancer & Oncology | Eating Disorders & Weight Management | Eloxatin | Gastric (Stomach) Cancer | Gastroenterology | Study | Thrombocytopenia | Toxicology | Xeloda